(2R,3S,4R,5R,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2S,3R,4S,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1R,2S,4R,5'R,6R,7R,8S,9S,12R,13R,16R,18R,19R)-19-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Internal ID | 8a312e42-9065-4338-8dc2-e918a0d5be67 |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins |
IUPAC Name | (2R,3S,4R,5R,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2S,3R,4S,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1R,2S,4R,5'R,6R,7R,8S,9S,12R,13R,16R,18R,19R)-19-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
SMILES (Canonical) | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)C)O)C)C)OC1 |
SMILES (Isomeric) | C[C@@H]1CC[C@@]2([C@@H]([C@@H]3[C@H](O2)C[C@@H]4[C@@]3(CC[C@@H]5[C@H]4C[C@H]([C@H]6[C@@]5(CC[C@H](C6)O[C@@H]7[C@H]([C@@H]([C@H]([C@@H](O7)CO)O[C@@H]8[C@H]([C@@H]([C@H]([C@@H](O8)CO)O)O[C@@H]9[C@H]([C@@H]([C@H](CO9)O)O)O)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)O)O)O)O)C)O)C)C)OC1 |
InChI | InChI=1S/C56H92O28/c1-20-5-10-56(74-18-20)21(2)34-29(84-56)13-25-23-12-27(61)26-11-22(6-8-54(26,3)24(23)7-9-55(25,34)4)75-50-43(71)40(68)45(33(17-60)79-50)80-53-48(47(38(66)32(16-59)78-53)82-49-41(69)35(63)28(62)19-73-49)83-52-44(72)46(37(65)31(15-58)77-52)81-51-42(70)39(67)36(64)30(14-57)76-51/h20-53,57-72H,5-19H2,1-4H3/t20-,21-,22-,23-,24-,25+,26+,27-,28+,29-,30+,31+,32+,33+,34-,35-,36+,37+,38+,39-,40+,41+,42+,43+,44+,45+,46-,47-,48+,49-,50+,51-,52-,53-,54-,55+,56-/m1/s1 |
InChI Key | GRTVHADQQMGAAO-WAOFJNROSA-N |
Popularity | 0 references in papers |
Molecular Formula | C56H92O28 |
Molecular Weight | 1213.30 g/mol |
Exact Mass | 1212.57751227 g/mol |
Topological Polar Surface Area (TPSA) | 434.00 Ų |
XlogP | -3.30 |
There are no found synonyms. |
![2D Structure of (2R,3S,4R,5R,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2S,3R,4S,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1R,2S,4R,5'R,6R,7R,8S,9S,12R,13R,16R,18R,19R)-19-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol 2D Structure of (2R,3S,4R,5R,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2R,3S,4R,5S,6S)-2-[(2S,3R,4S,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1R,2S,4R,5'R,6R,7R,8S,9S,12R,13R,16R,18R,19R)-19-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4R,5S)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol](https://plantaedb.com/storage/docs/compounds/2023/11/e9fadd70-8585-11ee-a189-27055f177b39.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
No predicted properties yet! |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.00% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.25% | 91.11% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 96.10% | 96.61% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 94.32% | 97.09% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 94.08% | 95.93% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 92.66% | 94.45% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 92.39% | 97.25% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 92.22% | 95.50% |
CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 91.07% | 95.58% |
CHEMBL237 | P41145 | Kappa opioid receptor | 90.60% | 98.10% |
CHEMBL206 | P03372 | Estrogen receptor alpha | 90.39% | 97.64% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 90.08% | 100.00% |
CHEMBL233 | P35372 | Mu opioid receptor | 89.62% | 97.93% |
CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 89.58% | 97.86% |
CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 89.45% | 92.86% |
CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 88.29% | 97.31% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 87.77% | 92.50% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 87.70% | 96.77% |
CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 87.15% | 96.21% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 85.60% | 97.29% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 84.61% | 89.05% |
CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 84.43% | 91.24% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.85% | 95.89% |
CHEMBL4016 | P42262 | Glutamate receptor ionotropic, AMPA 2 | 83.68% | 86.92% |
CHEMBL241 | Q14432 | Phosphodiesterase 3A | 83.68% | 92.94% |
CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 83.52% | 97.50% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.37% | 100.00% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 83.05% | 89.00% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 81.96% | 86.33% |
CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 81.24% | 93.04% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 81.19% | 97.28% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 80.95% | 92.62% |
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR | 80.88% | 92.78% |
CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 80.70% | 92.32% |
CHEMBL5524 | Q99873 | Protein-arginine N-methyltransferase 1 | 80.45% | 96.67% |
CHEMBL1907601 | P11802 | Cyclin-dependent kinase 4/cyclin D1 | 80.17% | 98.99% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Allium obliquum |
PubChem | 162928017 |
LOTUS | LTS0182487 |
wikiData | Q105016534 |